Cleared Traditional

K233307 - Intensity Pulsed Light Therapy System (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233307 · Beijing Adss Development Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
168d
Days
Class 2
Risk

K233307 is an FDA 510(k) clearance for the Intensity Pulsed Light Therapy System. Classified as Powered Light Based Non-laser Surgical Instrument With Thermal Effect (product code ONF), Class II - Special Controls.

Submitted by Beijing Adss Development Co., Ltd. (Beijing, CN). The FDA issued a Cleared decision on March 15, 2024 after a review of 168 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Beijing Adss Development Co., Ltd. devices

Submission Details

510(k) Number K233307 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2023
Decision Date March 15, 2024
Days to Decision 168 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d slower than avg
Panel avg: 114d · This submission: 168d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ONF Powered Light Based Non-laser Surgical Instrument With Thermal Effect
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Light Based Non-laser Device That Provides Thermal Effect Including Broad Spectrum Source Devices Such As Intense Pulse Light (ipl). Typically, Indicated To Be Used In Medical Specialties Of General And Plastic Surgery And Of Dermatology/aesthetic. Indication For Use Can Be General And/or Specific.the Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Or Remove Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Shanghai Truthful Information Technology Co., Ltd.
Boyle Wang

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - ONF Powered Light Based Non-laser Surgical Instrument With Thermal Effect

All 72
Devices cleared under the same product code (ONF) and FDA review panel - the closest regulatory comparables to K233307.
Intense Pulsed Light Therapy Device (MMABM-1)
K251545 · Micowey Medical Equipment (Guangxi) Co., Ltd. · Sep 2025
MEDILIGHT
K231952 · Medicreations, LLC · Sep 2025
IPL Treatment Device (MDSQMC-01)
K243123 · Medusa (Guangxi)Medical Devices Co., Ltd. · Jul 2025
DEKA LOTUS
K250281 · El.En S.P.A. · Feb 2025
Intense Pulsed Light Treatment System (LK-PT)
K242440 · Nanjing Bestview Laser S&T Co., Ltd. · Nov 2024
MULA (K2-A1)
K240314 · Guangzhou Ciellulu Photoelectric Technology Co., Ltd. · Aug 2024